» Articles » PMID: 24936458

A 3D Sphere Culture System Containing Functional Polymers for Large-scale Human Pluripotent Stem Cell Production

Overview
Publisher Cell Press
Specialty Cell Biology
Date 2014 Jun 18
PMID 24936458
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Utilizing human pluripotent stem cells (hPSCs) in cell-based therapy and drug discovery requires large-scale cell production. However, scaling up conventional adherent cultures presents challenges of maintaining a uniform high quality at low cost. In this regard, suspension cultures are a viable alternative, because they are scalable and do not require adhesion surfaces. 3D culture systems such as bioreactors can be exploited for large-scale production. However, the limitations of current suspension culture methods include spontaneous fusion between cell aggregates and suboptimal passaging methods by dissociation and reaggregation. 3D culture systems that dynamically stir carrier beads or cell aggregates should be refined to reduce shearing forces that damage hPSCs. Here, we report a simple 3D sphere culture system that incorporates mechanical passaging and functional polymers. This setup resolves major problems associated with suspension culture methods and dynamic stirring systems and may be optimal for applications involving large-scale hPSC production.

Citing Articles

Impact of mesenchymal stem cell size and adhesion modulation on in vivo distribution: insights from quantitative PET imaging.

Ji X, Wang L, Zhong Y, Xu Q, Yan J, Pan D Stem Cell Res Ther. 2024; 15(1):456.

PMID: 39609885 PMC: 11606219. DOI: 10.1186/s13287-024-04078-4.


Hydrogel microsphere stem cell encapsulation enhances cardiomyocyte differentiation and functionality in scalable suspension system.

Hashemi M, Finklea F, Hammons H, Tian Y, Young N, Kim E Bioact Mater. 2024; 43:423-440.

PMID: 39399838 PMC: 11471139. DOI: 10.1016/j.bioactmat.2024.08.043.


Atelocollagen supports three-dimensional culture of human induced pluripotent stem cells.

Nakashima Y, Tsukahara M Mol Ther Methods Clin Dev. 2024; 32(3):101302.

PMID: 39185274 PMC: 11342089. DOI: 10.1016/j.omtm.2024.101302.


Addressing bioreactor hiPSC aggregate stability, maintenance and scaleup challenges using a design of experiment approach.

Yehya H, Raudins S, Padmanabhan R, Jensen J, Bukys M Stem Cell Res Ther. 2024; 15(1):191.

PMID: 38956608 PMC: 11218057. DOI: 10.1186/s13287-024-03802-4.


Biofabrication of engineered blood vessels for biomedical applications.

Laowpanitchakorn P, Zeng J, Piantino M, Uchida K, Katsuyama M, Matsusaki M Sci Technol Adv Mater. 2024; 25(1):2330339.

PMID: 38633881 PMC: 11022926. DOI: 10.1080/14686996.2024.2330339.


References
1.
Singh H, Mok P, Balakrishnan T, Rahmat S, Zweigerdt R . Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. Stem Cell Res. 2010; 4(3):165-79. DOI: 10.1016/j.scr.2010.03.001. View

2.
Abbasalizadeh S, Rezaei Larijani M, Samadian A, Baharvand H . Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor. Tissue Eng Part C Methods. 2012; 18(11):831-51. DOI: 10.1089/ten.TEC.2012.0161. View

3.
Sakurai K, Shimoji M, Tahimic C, Aiba K, Kawase E, Hasegawa K . Efficient integration of transgenes into a defined locus in human embryonic stem cells. Nucleic Acids Res. 2010; 38(7):e96. PMC: 2853137. DOI: 10.1093/nar/gkp1234. View

4.
Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, Marshall V . Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282(5391):1145-7. DOI: 10.1126/science.282.5391.1145. View

5.
Olmer R, Lange A, Selzer S, Kasper C, Haverich A, Martin U . Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. Tissue Eng Part C Methods. 2012; 18(10):772-84. PMC: 3460618. DOI: 10.1089/ten.TEC.2011.0717. View